Bonus BioGroup Ltd. (TLV:BONS)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
24.50
+0.20 (0.82%)
Jul 23, 2025, 11:09 AM IDT
0.82%
Market Cap283.81M
Revenue (ttm)n/a
Net Income (ttm)-27.83M
Shares Out1.17B
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume42,254
Average Volume1,563,773
Open24.40
Previous Close24.30
Day's Range24.40 - 24.50
52-Week Range9.00 - 26.70
Beta0.82
RSI57.49
Earnings DateAug 28, 2025

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 49
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BONS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.